Vijay Ivaturi

P-SHOR Faculty Named to Leadership Positions in Professional Societies

August 21, 2023

Eberechukwu Onukwugha and Vijay Ivaturi are faculty members in the Department of Practice, Sciences, and Health Outcomes Research.

University of Maryland, Baltimore (UMB) Grants Pumas-AI Exclusive License of Analytics Platform to Enhance Drug Development

August 16, 2021

Company spun out of University of Maryland School of Pharmacy provides a sophisticated pharmaceutical modeling and simulation platform with upgraded Productivity and Compliance Suites.

SOP’s ATRIUM Cardiology Collaborative Launches New Mobile App

February 26, 2020

Application available to download for Android and iOS offers guidance to health care professionals in selecting and dosing anticoagulant therapy for patients.

Pumas-AI Launches Pumas Software to Advance Drug Development, Patient Care

July 19, 2019

New company established by School of Pharmacy faculty members releases its first software platform designed to assist strategic decision making across the fields of drug development and individualized patient care.

A Step Towards Precision Therapeutics in the Treatment of Complicated Infections

January 28, 2019

Researchers from the School of Pharmacy and Johns Hopkins University use PET scans and pharmacometric modeling to help inform dosing recommendations for first-line tuberculosis drug.

SOP, UCSF Partner for New Initiative on Pediatric Drug and Device Development

September 11, 2017

Partnership will facilitate the development of therapeutics for pediatric patients and provide research and education opportunities for faculty, students, and trainees.

Center for Translational Medicine Receives $1.7 Million Gift in Kind

February 13, 2015

Gift of software will benefit students in the School’s Master of Science in Pharmacometrics program and aid researchers in the Center for Translational Medicine.

FDA Awards Two Grants, $1.2 Million to Center for Translational Medicine

January 12, 2015

Grants will support the development of quantitative pharmacometric models to advance the evaluation of generic drugs.